Methylprednisolone (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Methylprednisolone drug offered from Actavis Pharma, Inc.. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
NON-PROPRIETARY NAME: | Methylprednisolone |
SUBSTANCE NAME: | METHYLPREDNISOLONE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-05-26 |
END MARKETING DATE: | 0000-00-00 |
Methylprednisolone HUMAN PRESCRIPTION DRUG Details:
Item Description | Methylprednisolone from Actavis Pharma, Inc. |
LABELER NAME: | Actavis Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 4(mg/1) |
START MARKETING DATE: | 2016-05-26 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0591-0790_373c17b7-e4cb-43f3-aa7d-045d08838f16 |
PRODUCT NDC: | 0591-0790 |
APPLICATION NUMBER: | ANDA040232 |
Other METHYLPREDNISOLONE Pharmaceutical Manufacturers / Labelers: